source
- Novo Nordisk invests $380M to expand manufacturing in Czech Republic and China, while Cellares raises $50M Series DNovo Nordisk announced a significant investment to broaden its manufacturing footprint in both China and the Czech Republic. In the Czech Republic, the company is allocating roughly $380 million t…
- FDA advisory panel unanimously backs Moderna’s flu vaccineThe FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend Moderna’s seasonal influenza vaccine. The vote overturns earlier hesitations from previous agen…